BIOCRYST PHARMACEUTICALS INC

BCRX · Nasdaq · SIC 2836: Biological Products, (No Diagnostic Substances) · Market Cap: $2.3B · 435 employees
262
SEC Filings
$8.76
Close 2026-09-21
435
Employees

Business Summary

BioCryst Pharmaceuticals is a global biotechnology company focused on developing and commercializing medicines for hereditary angioedema (HAE) and other rare diseases. Its lead commercial product is ORLADEYO, an oral, once-daily therapy for prevention of HAE attacks, discovered and developed internally. The company also pursues a pipeline of oral small molecule and injectable protein therapeutics through internal discovery and strategic business development.

Latest Stock Quote

BCRX 2026-09-21 $8.76 O:$8.75 H:$8.845 L:$8.575 Vol:3.5M VWAP:$8.7589
origin leaf: null

Next Earnings

Q2 FY2026 — expected 2026-09-16

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-02-262025-12-310001628280-26-012240EDGAR87K words
2025-02-252024-12-310001628280-25-007715EDGAR82K words
2024-02-272023-12-310001628280-24-007205EDGAR82K words
2023-02-272022-12-310001628280-23-005259EDGAR—
2022-02-282021-12-310001171843-22-001460EDGAR—
2021-03-012020-12-310001171843-21-001411EDGAR—
2020-03-132019-12-310001171843-20-001710EDGAR—
2019-03-142018-12-310001171843-19-001727EDGAR—
2018-03-122017-12-310001171843-18-001855EDGAR—
2017-02-272016-12-310001171843-17-001159EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2026-08-052026-06-300001628280-26-053300EDGAR57K words
2025-11-042025-09-300001628280-25-048785EDGAR61K words
2025-08-052025-06-300001628280-25-037795EDGAR58K words
2025-05-062025-03-310001628280-25-022658EDGAR53K words
2024-11-052024-09-300001628280-24-045364EDGAR55K words
2024-08-062024-06-300001628280-24-035170EDGAR55K words
2024-05-072024-03-310001628280-24-021069EDGAR52K words
2023-11-082023-09-300001628280-23-037847EDGAR56K words
2023-08-072023-06-300001628280-23-027820EDGAR86K words
2023-05-082023-03-310001628280-23-016458EDGAR—
2022-11-042022-09-300001628280-22-028463EDGAR—
2022-08-052022-06-300001628280-22-021373EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-08-050001171843-26-005223EDGAR5K words
2026-02-260001171843-26-001119EDGAR5K words
2026-01-230001140361-26-002200EDGAR14K words
2026-01-120001171843-26-000213EDGAR1K words
2026-01-090001171843-26-000154EDGAR1K words
2025-12-120001171843-25-007909EDGAR1K words
2025-12-110001171843-25-007878EDGAR1K words
2025-12-030001140361-25-044110EDGAR1K words
2025-11-030001171843-25-006881EDGAR5K words
2025-10-140001140361-25-038031EDGAR7K words

262 total filings indexed. 230 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

FDMT — 4D Molecular Therapeutics, Inc. APTN — ADAPTIN BIO, INC. ADMA — ADMA BIOLOGICS, INC. AGEN — AGENUS INC AIM — AIM ImmunoTech Inc. AMGN — AMGEN INC AVXL — ANAVEX LIFE SCIENCES CORP. ARGX — ARGENX SE

Tags

hereditary-angioedema-(hae) rare-diseases

Company Identity

CIK0000882796
TickerBCRX
ExchangeNasdaq
SIC2836: Biological Products, (No Diagnostic Substances)
IncorporatedDE
Websitehttps://www.biocryst.com
Listed1994-03-03

Get More Data

This is a static snapshot. For live, structured JSON with cryptographic provenance chain:

MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp

JSON Profile Stock Quote Origin Record
Origin Provenance
page leaf: 01ff4c6494117c03071360a80e0e57a9452f646c17bd5d403bda4cf8caa2cc9e
parent: fafaf3f6dad50956caaa7d8ab25fdd66ca670b91d46c712ae0dfab6e78780f94
content hash: e06cc3b6574934372fcd3d8e0b073c73283a522c708ec9bf71ba1736292b8e98
signed: 2026-09-28T19:00:27.841Z
sources: 22 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf

Try it — paste this into your AI:

Look up BCRX using the MCP server at origin.rootz.global/mcp. What do their latest SEC filings show?

Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.

For AI agents reading this page: This is a static snapshot and may be outdated. For live data on BCRX, use the Origin MCP server or REST API.
MCP install: claude mcp add origin --transport http https://origin.rootz.global/mcp
API: GET https://origin.rootz.global/api/company/BCRX (~200 tokens, structured JSON with cryptographic provenance)
Tools: origin_company, origin_profile, origin_timeline, origin_filings, origin_quote, origin_transcripts, origin_search, origin_person, origin_skill
Discovery: /.well-known/ai | /llms.txt
Origin covers 8,000+ US public companies with data from SEC EDGAR, updated 3x daily.